Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1446642

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1446642

USA Glucosamine Market Size, Share & Trends Analysis Report By Application, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others), Outlook and Forecast, 2023 - 2030

PUBLISHED:
PAGES: 64 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 500
PDF (Site License)
USD 640
PDF (Enterprisewide License)
USD 820

Add to Cart

The USA Glucosamine Market size is expected to reach $211.83 million by 2030, rising at a market growth of 3.3% CAGR during the forecast period. In the year 2022, the market attained a volume of 13,183.69 Tonnes, experiencing a growth of 2.6% (2019-2022).

The glucosamine market in the United States has experienced significant growth in recent years, driven by factors such as an aging population, increasing awareness of joint health, and a growing trend toward self-care. The U.S. consumer landscape has witnessed a notable shift towards health and wellness, with more individuals taking an active interest in preventive healthcare.

Companies often leverage educational campaigns to inform consumers about the benefits of glucosamine in supporting joint health. These campaigns emphasize the importance of early intervention and preventative measures, resonating with health-conscious individuals seeking long-term solutions to joint-related issues. Regulatory factors and product quality are crucial considerations for consumers in the U.S., influencing their trust in a brand or product. Manufacturers that adhere to stringent quality standards, provide transparent information about their sourcing and production processes, and comply with regulatory requirement.

The COVID-19 pandemic has also impacted the glucosamine market in the United States. While the pandemic initially disrupted supply chains and led to a temporary decline in consumer spending, the focus on health and wellness has remained a priority. In fact, the pandemic has underscored the importance of maintaining a healthy immune system and overall well-being, prompting consumers to pay more attention to their nutritional choices, including supplements like glucosamine.

Market Trends

Increasing Use in The Manufacturing of Dietary Supplements

The glucosamine market in the U.S. has witnessed a significant surge in the utilization of this vital compound, particularly in the manufacturing of dietary supplements. Glucosamine, a naturally occurring compound in the human body, is crucial for maintaining healthy joints and cartilage. In recent years, its popularity has soared in the U.S., driven by the increasing awareness of joint health and a growing aging population seeking ways to support overall joint function.

Consumers are becoming more health-conscious, actively seeking preventive measures to address joint-related issues. This has led to a booming industry for dietary supplements incorporating glucosamine as a primary ingredient, aiming to promote joint health and alleviate symptoms associated with osteoarthritis. Manufacturers in the U.S. are capitalizing on this trend by incorporating glucosamine into various dietary supplement formulations. Whether in the form of pills, capsules, or powders, glucosamine is increasingly being included as a key component, often combined with other joint-supporting ingredients such as chondroitin and MSM (methylsulfonylmethane).

The dietary supplement industry in the U.S. has become a powerhouse, with consumers actively seeking products that provide essential nutrients and targeted health benefits. Glucosamine fits seamlessly into this paradigm, with scientific studies supporting its potential efficacy in joint health.

Moreover, the U.S. Food and Drug Administration (FDA) has recognized glucosamine as a generally safe ingredient, further fueling its inclusion in dietary supplements. This regulatory acknowledgment gives manufacturers and consumers' confidence in the quality and safety of Glucosamine-containing products. According to the Centers for Disease Control and Prevention, 57.6% of adults aged 20 and over reported using dietary supplements in the United States. Usage was more prevalent among women, with 63.8% incorporating dietary supplements into their routines, compared to 50.8% of men in 2018. This trend aligns with the growing utilization of glucosamine in the manufacturing of dietary supplements, contributing to the rising demand for glucosamine market in the U.S. Thus, the surge in glucosamine utilization in the U.S. reflects a growing consumer emphasis on joint health, driving its incorporation into diverse dietary supplements

Rising Popularity of Sports and Fitness

In the United States, the glucosamine market is significantly influenced by the widespread popularity of sports and fitness activities. As Americans increasingly prioritize their health and wellness, there has been a surge in demand for supplements that support joint health, with glucosamine playing a pivotal role. The thriving sports culture in the U.S. has led to a growing awareness of the importance of maintaining joint flexibility and function. Athletes and fitness enthusiasts, ranging from casual gym-goers to professional athletes, are actively seeking products that aid in preventing and managing joint-related issues.

The aging population in the U.S. also contributes significantly to the demand for glucosamine. As individuals age, joint health becomes a primary concern, and many turn to supplements like glucosamine to alleviate symptoms of conditions such as osteoarthritis. The desire to maintain an active lifestyle into old age further fuels the industry for joint health supplements.

Marketing efforts by companies in the U.S. emphasize the benefits of glucosamine for individuals pursuing an active lifestyle. Advertisements often target sports enthusiasts, runners, weightlifters, and other fitness-conscious demographics. Additionally, endorsements from athletes and fitness influencers contribute to the popularity of glucosamine products in the U.S. industry. Therefore, the U.S. glucosamine market thrives on the intersection of a health-conscious population, a robust sports culture, and a growing aging demographic seeking joint health support.

Competition Analysis

The glucosamine market in the United States is a dynamic and competitive sector driven by the growing awareness of joint health and the aging population's increasing interest in maintaining mobility. In the U.S., several companies play a significant role in this industry, offering a variety of glucosamine products to cater to the diverse needs of consumers.

One of the key players in the U.S. glucosamine market is Nutramax Laboratories. Headquartered in South Carolina, the company is a leading manufacturer of nutritional supplements, including glucosamine-based products. Their flagship brand, Cosamin, is well-known for its joint health formulations that often include glucosamine as a key ingredient. Nutramax has built a strong reputation for producing high-quality supplements backed by scientific research, making it a trusted choice among consumers seeking joint support.

Another major player is Schiff Nutrition International, a Reckitt Benckiser Group plc subsidiary. Schiff is prominent in the U.S. dietary supplement industry, offering glucosamine products under brands like Move Free. The company emphasizes innovation in its formulations, incorporating additional ingredients to enhance joint health. Schiff's commitment to research and development has positioned it as a leading choice for consumers looking for effective and advanced glucosamine supplements.

Nature's Bounty, headquartered in New York, is a well-established company in the nutritional supplement industry. With a diverse product portfolio, Nature's Bounty offers various glucosamine formulations to address joint health. The company's commitment to quality and consumer satisfaction has contributed to its strong presence in the U.S. industry. Nature's Bounty products are widely available in retail outlets, making them accessible to a broad consumer base.

In recent years, private-label brands offered by major retailers have gained traction in the glucosamine market. These brands often collaborate with contract manufacturers to produce high-quality supplements sold under the retailer's name. Retail giants like Walmart, Costco, and Amazon have entered the glucosamine market with their private-label offerings, providing consumers with affordable alternatives without compromising quality.

List of Key Companies Profiled (Global Leaders)

  • Teva Pharmaceutical Industries Ltd.
  • Laboratoires Expanscience S.A.
  • Nutramax Laboratories, Inc.
  • Amway Corporation
  • CellMark AB
  • Alfa Chemical Group
  • Cargill, Incorporated
  • Simply Supplements
  • Reckitt Benckiser Group PLC

USA Glucosamine Market Report Segmentation

By Application

  • Supplement
  • Food & Beverage
  • Others

By Product

  • Glucosamine Sulfate
  • Glucosamine Hydrochloride
  • N-acetyl Glucosamine
  • Others

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 USA Glucosamine Market, by Application
    • 1.4.2 USA Glucosamine Market, by Product
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Opportunities
    • 2.2.3 Market Restraints
    • 2.2.4 Market Challenges
  • 2.3 Porter's Five Forces Analysis

Chapter 3. US Glucosamine Market

  • 3.1 US Glucosamine Market by Application
  • 3.2 US Glucosamine Market by Product

Chapter 4. Company Profiles - Global Leaders

  • 4.1 Teva Pharmaceutical Industries Ltd.
    • 4.1.1 Company Overview
    • 4.1.2 Financial Analysis
    • 4.1.3 Regional Analysis
    • 4.1.4 Research & Development Expenses
    • 4.1.5 SWOT Analysis
  • 4.2 Laboratoires Expanscience S.A.
    • 4.2.1 Company Overview
    • 4.2.2 SWOT Analysis
  • 4.3 Nutramax Laboratories, Inc.
    • 4.3.1 Company Overview
    • 4.3.2 SWOT Analysis
  • 4.4 Amway Corporation
    • 4.4.1 Company Overview
    • 4.4.2 SWOT Analysis
  • 4.5 CellMark AB
    • 4.5.1 Company Overview
    • 4.5.2 SWOT Analysis
  • 4.6 Alfa Chemical Group
    • 4.6.1 Company Overview
    • 4.6.2 SWOT Analysis
  • 4.7 Cargill, Incorporated
    • 4.7.1 Company Overview
    • 4.7.2 SWOT Analysis
  • 4.8 Simply Supplements
    • 4.8.1 Company Overview
    • 4.8.2 SWOT Analysis
  • 4.9 Reckitt Benckiser Group PLC
    • 4.9.1 Company Overview
    • 4.9.2 Financial Analysis
    • 4.9.3 Segmental and Regional Analysis
    • 4.9.4 Research & Development Expenses
    • 4.9.5 SWOT Analysis

LIST OF TABLES

  • TABLE 1 US Glucosamine Market, 2019 - 2022, USD Million
  • TABLE 2 US Glucosamine Market, 2023 - 2030, USD Million
  • TABLE 3 US Glucosamine Market, 2019 - 2022, Tonnes
  • TABLE 4 US Glucosamine Market, 2023 - 2030, Tonnes
  • TABLE 5 US Glucosamine Market by Application, 2019 - 2022, USD Million
  • TABLE 6 US Glucosamine Market by Application, 2023 - 2030, USD Million
  • TABLE 7 US Glucosamine Market by Application, 2019 - 2022, Tonnes
  • TABLE 8 US Glucosamine Market by Application, 2023 - 2030, Tonnes
  • TABLE 9 US Glucosamine Market by Product, 2019 - 2022, USD Million
  • TABLE 10 US Glucosamine Market by Product, 2023 - 2030, USD Million
  • TABLE 11 US Glucosamine Market by Product, 2019 - 2022, Tonnes
  • TABLE 12 US Glucosamine Market by Product, 2023 - 2030, Tonnes
  • TABLE 13 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 14 Key Information - Laboratoires Expanscience S.A.
  • TABLE 15 Key information - Nutramax Laboratories, Inc.
  • TABLE 16 Key Information - Amway Corporation
  • TABLE 17 Key Information - CellMark AB
  • TABLE 18 Key Information - Alfa Chemical Group
  • TABLE 19 Key Information - Cargill, Incorporated
  • TABLE 20 Key Information - Simply Supplements
  • TABLE 21 Key information - Reckitt Benckiser Group PLC
  • FIG 1 Methodology for the research
  • FIG 2 US Glucosamine Market, 2019 - 2030, USD Million
  • FIG 3 Key Factors Impacting Glucosamine Market
  • FIG 4 Porter's Five Forces Analysis - Glucosamine Market
  • FIG 5 US Glucosamine Market Share by Application, 2022
  • FIG 6 US Glucosamine Market Share by Application, 2030
  • FIG 7 US Glucosamine Market by Application, 2019 - 2030, USD Million
  • FIG 8 US Glucosamine Market Share by Product, 2022
  • FIG 9 US Glucosamine Market Share by Product, 2030
  • FIG 10 US Glucosamine Market by Product, 2019 - 2030, USD Million
  • FIG 11 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
  • FIG 12 SWOT Analysis: Laboratoires Expanscience S.A.
  • FIG 13 SWOT Analysis: Nutramax Laboratories, Inc.
  • FIG 14 SWOT Analysis: Amway Corporation
  • FIG 15 SWOT Analysis: CellMark AB
  • FIG 16 SWOT Analysis: Alfa Chemical Group
  • FIG 17 SWOT Analysis: Cargill, Incorporated
  • FIG 18 SWOT Analysis: Simply Supplements
  • FIG 19 SWOT Analysis: Reckitt Benckiser Group PLC
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!